rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
10
|
pubmed:dateCreated |
2008-11-11
|
pubmed:abstractText |
To study the Adverse Drug Reactions occurring during DOTS therapy and to assess their causality, severity and predisposing factors.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0030-9982
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
58
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
531-6
|
pubmed:dateRevised |
2009-1-22
|
pubmed:meshHeading |
pubmed-meshheading:18998303-Adult,
pubmed-meshheading:18998303-Antitubercular Agents,
pubmed-meshheading:18998303-Directly Observed Therapy,
pubmed-meshheading:18998303-Female,
pubmed-meshheading:18998303-Humans,
pubmed-meshheading:18998303-Isoniazid,
pubmed-meshheading:18998303-Male,
pubmed-meshheading:18998303-Middle Aged,
pubmed-meshheading:18998303-Nepal,
pubmed-meshheading:18998303-Time Factors,
pubmed-meshheading:18998303-Young Adult
|
pubmed:year |
2008
|
pubmed:articleTitle |
Study of adverse drug reactions caused by first line anti-tubercular drugs used in directly observed treatment, short course (DOTS) therapy in Western Nepal, Pokhara.
|
pubmed:affiliation |
Department of Pharmacology, Manipal College of Medical Sciences, Pokhara, Nepal.
|
pubmed:publicationType |
Journal Article
|